• A SHARED VISION
  • Editorial
  • Mission
  • Fundamentals
  • Philanthropy
  • History

• TEAMS
  • Governance
    • Organization chart
    • Management
  • Key figures
  • An International Presence
    bioMérieux Transgene Silliker
    ABL, Inc. Mérieux Développement

• AN OUTSTANDING INNOVATION POLICY
  • Strategy
  • The Mérieux Research Grants
  • Joint research units

• PUBLIC HEALTH PROJECTS
  • Personalized medicine
    • Stakes
    • All about ADNA
  • Nutrition & Health
    • Stakes
    • Global Offer Silliker / bioMérieux

TEAMS

Management

• Alain Mérieux: Chairman
• Alexandre Mérieux: Vice President

• Michel Baguenault: Directeur Général Délégué
• Dominique Takizawa: Chief Financial Officer

• Pr Christian Bréchot: Vice President of Medical and Scientific Departement
• Dr Christine M’Rini: Scientific Director
• Philippe Cleuziat: Director of the ADNA Program

• Anne de Chiffrevillle: Communications Director

• Alain Mérieux: Chairman

• Alexandre Mérieux: Directeur Général Délégué

• Stéphane Bancel: Chief Executive Officer

• Philippe Archinard: Chairman and Chief Executive Officer

• Russ Flowers: Chairman

• Philippe Sans: Chief Executive Officer

• Johannes Burlin: Chairman

• Thomas VanCott: Chief Executive Officer

• Alexandre Mérieux: Chairman

• François Valencony: Chief Executive Officer